Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.
Reckamp KL, Gardner BK, Figlin RA, Elashoff D, Krysan K, Dohadwala M, Mao J, Sharma S, Inge L, Rajasekaran A, Dubinett SM. Reckamp KL, et al. J Thorac Oncol. 2008 Feb;3(2):117-24. doi: 10.1097/JTO.0b013e3181622bef. J Thorac Oncol. 2008. PMID: 18303430 Free article. Clinical Trial.
Novel mechanisms and targets: miscellaneous agents.
Reckamp KL. Reckamp KL. J Thorac Oncol. 2011 Nov;6(11 Suppl 4):S1812-4. doi: 10.1097/01.JTO.0000407569.29900.73. J Thorac Oncol. 2011. PMID: 22005541 Free article. No abstract available.
Phosphatidylinositol-3-kinase pathway.
Reckamp KL. Reckamp KL. J Thorac Oncol. 2012 Dec;7(16 Suppl 5):S383-4. doi: 10.1097/JTO.0b013e31826df11c. J Thorac Oncol. 2012. PMID: 23160326 Free article. Review. No abstract available.
A 75-year-old man with progressive bronchioalveolar carcinoma.
Baikadi M, Lovly C, Horn L, Reckamp KL, Noonan K, Laskin J, Morris GJ. Baikadi M, et al. Among authors: reckamp kl. Semin Oncol. 2013 Feb;40(1):e1-8. doi: 10.1053/j.seminoncol.2012.11.004. Semin Oncol. 2013. PMID: 23391120 Free PMC article. No abstract available.
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.
Reckamp KL, Giaccone G, Camidge DR, Gadgeel SM, Khuri FR, Engelman JA, Koczywas M, Rajan A, Campbell AK, Gernhardt D, Ruiz-Garcia A, Letrent S, Liang J, Taylor I, O'Connell JP, Jänne PA. Reckamp KL, et al. Cancer. 2014 Apr 15;120(8):1145-54. doi: 10.1002/cncr.28561. Epub 2014 Feb 5. Cancer. 2014. PMID: 24501009 Free PMC article. Clinical Trial.
186 results